Status:
COMPLETED
Trial of Terbutaline for the Treatment of Status Asthmaticus in Children
Lead Sponsor:
Connecticut Children's Medical Center
Conditions:
Status Asthmaticus
Eligibility:
All Genders
Up to 18 years
Phase:
PHASE4
Brief Summary
Although widely used for the treatment of pediatric status asthmaticus, intravenous terbutaline has potentially significant side effects; may not improve outcomes; and may increase Intensive Care Unit...
Eligibility Criteria
Inclusion
- Admission to the Connecticut Children's Medical Center (CCMC) Pediatric Intensive Care Unit (PICU) with a primary admission diagnosis of status asthmaticus
- Modified Pulmonary Index Score (MPIS) of greater than or equal to 12
- Age between birth and 18 years old
Exclusion
- Pre-existing cardiac or pulmonary disease
- Existing respiratory failure (requiring invasive or non-invasive mechanical ventilation)
- Hemodynamic or cardiovascular instability requiring inotropic support
- The patient meets one of the criteria for withdrawal from the study due to patient safety concerns
Key Trial Info
Start Date :
October 1 2003
Trial Type :
INTERVENTIONAL
End Date :
October 1 2006
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00124995
Start Date
October 1 2003
End Date
October 1 2006
Last Update
February 15 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CT Children's Medical Center
Hartford, Connecticut, United States, 06106